What drove the intraday gain in GBT.PA stock today?

The intraday gain to **€9.24** on 19 Mar 2026 came with volume **13,540**, above average, and oversold technical signals. Market participants reacted to valuation gaps and short-term buying interest in Healthcare small caps.

What is Meyka AI's forecast for GBT.PA stock?

Meyka AI's forecast model projects a yearly price of **€18.13** for GBT.PA stock, implying roughly **+96.15%** versus the current **€9.24**. Forecasts are model-based projections and not guarantees.

What are the main risks for investors in GBT.PA stock?

Primary risks include negative EPS **-8.93**, weak interest coverage **-24.26**, high inventory days **322.15**, and leverage with debt-to-equity **1.06**. These can pressure earnings and liquidity.

What price targets should traders watch for GBT.PA stock?

Key levels: near-term resistance **€13.27**, base target **€12.00**, Meyka AI yearly target **€18.13**, and upside to the 52-week high **€27.60**. Position sizing should reflect volatility and risk tolerance.

EU Stocks

GBT.PA Guerbet SA EURONEXT jumps 10.00% intraday at €9.24: watch forecast and targets

ByDanny Kontos March 19, 2026March 19, 2026

GBT.PA stock led intraday gainers on 19 Mar 2026 after a 10.00% rise to €9.24 on EURONEXT, backed by a volume uptick to 13,540 shares. Traders priced a recovery versus the 50-day average of €13.27 and the 200-day average of €16.76. We cover why Guerbet SA (GBT.PA) moved, how fundamentals and technicals line up, and what model-based targets suggest for investors watching Healthcare names in Europe.